Patient Blood Management Program in Total Hip or Total Knee Arthroplasty

Status Completed

Clinical Trial Summary

Total hip and knee arthroplasty are among the most common surgical procedures for which blood transfusion is prescribed. Patient blood management program has been proposed to decrease the need for transfusion. This program involve three pillars: preoperative improvement of erythropoiesis, intraoperative reduction of bleeding and postoperative management of anemia.

Among the different steps of this program, reduction of bleeding and optimization of anemia are gaining popularity, but preoperative improvement of erythropoiesis is underused. The preoperative step of the blood management program is not systematically used because it requires a complex organization, is considered expensive, and finally because the others available techniques to reduce blood transfusion are easier to implement.

The aim of this study was to assess, within a patient blood management program, the effectiveness of erythropoietin on reducing allogenic blood transfusion and anemia in patients requiring elective total hip or knee arthroplasty. "

Clinical Trial Description

This is a post-hoc analysis using part of the patients involved in the Cross Iron Study (Anesthesiology. 2018 Oct;129(4):710-720 ) Included patients were all the patients scheduled for elective primary total hip or knee arthroplasty and assessed by an anesthesiologist involved in the Cross Iron Study. Exclusion criteria were pregnancy, age under 18 years old, systemic infection, bilateral arthroplasty, revision arthroplasty, and participation in a preoperative autologous donation program.

This was a observational study. The patient blood management program included: erythropoietin with iron supplementation if preoperative hemoglobin was lower than 13 g/dl; tranexamic acid during surgery; intravenous iron postoperatively and use of prespecified thresholds for homologous blood transfusion. Blood transfusion and anemia were assessed until day 5 or discharge, whichever came first. Major thromboembolic or cardiovascular events were assessed during admission and one month after discharge. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04137484
Study type	Observational
Source	University Hospital, Montpellier
Contact
Status	Completed
Phase
Start date	July 1, 2014
Completion date	August 1, 2016

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04058743` - Nickel Sensitivity	N/A
Completed	`NCT06321952` - Comparison of Accuracy and Functional Outcome Between Robotic and Gyroscopic Assisted Surgery in Primary TKA	N/A
Recruiting	`NCT06005623` - Motivational Feedback Following Total or Unicompartmental Knee Arthroplasty	N/A
Completed	`NCT06159205` - Core Stability Via Telerehabitation on TKA	N/A
Terminated	`NCT03665233` - Virtual Reality for Post Operative Pain Management After Total Knee Arthroplasty	N/A
Recruiting	`NCT04229368` - Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications	N/A
Withdrawn	`NCT03840122` - ACB + IPACK Block With or Without Local Infiltration in RA-TKA	N/A
Recruiting	`NCT05583630` - Ligament Tension Measurement in Knee Arthroplasty
Recruiting	`NCT06120023` - Post-Market Clinical Follow Up for Total Knee Arthroplasty System Madison
Completed	`NCT05875324` - Effects of Virtual Reality in TKA Patients	N/A
Completed	`NCT03230942` - Effect of Pre-op Patient Education on Functional Outcomes After TKA	N/A
Completed	`NCT03302832` - Effectiveness of Reduced Frequency Physical Therapy in Total Knee Arthroplasty	N/A
Completed	`NCT03454256` - Virtual Reality Rehabilitation in Patients With Total Knee Replacement	N/A
Completed	`NCT05802368` - Hemophilic Knee Arthropathy Virtual Reality	N/A
Completed	`NCT05478005` - Function and Pain Following Knee Replacement	N/A
Recruiting	`NCT03495232` - Persona Cohort Nordic Multicenter Study
Completed	`NCT04183673` - Laser + Cryo-thermal Therapy Following Total Knee Replacement Surgery	N/A
Not yet recruiting	`NCT06337123` - Physica TT Tibial Plate Follow up Study
Completed	`NCT04883788` - The Impact of COVID-19 Pandemic on Hip and Knee Replacement
Active, not recruiting	`NCT04598568` - Post-market Clinical Follow-up on the balanSys UNI Knee Prosthesis Implanted With a Spacer Block Surgical Technique

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.